Abstract Body

Virus-driven clonal expansion of latently infected memory CD4+ T cells may provide a mechanism of HIV-1 persistence in the presence of suppressive antiretroviral therapy. The only conclusive way to prove the presence of a clonally expanded infected cell is to sequence complete, identical viral genomes and integration sites multiple times in independent experiments. Due to the prohibitive difficulty of this measurement, many studies assume clonality when independent viral sequences are identical in short PCR amplicons of ~500-1500bp. In this study, we analyzed previously published full-length HIV-1 sequence alignments from 28 patients to determine which PCR amplicons, if any, are sufficient to demonstrate the clonality of an entire viral genome.

We analyzed full-length HIV-1 sequences from plasma RNA (6 patients), resting CD4+ T cell proviral DNA (7 patients treated during acute infection, 9 patients treated during chronic infection), and DNA from p24 antigen-negative quantitative viral outgrowth assay culture wells (6 patients). We analyzed between 5 and 121 unique sequences (mean=25, median=16) per patient. We compared the apparent clonality of each patient alignment within previously published PCR amplicons in the gag-pol and envelope V3-V4 regions. We also measured the apparent clonality of each alignment within hypothetical amplicons of various fixed lengths across the genome to identify the optimal genomic region(s) for primer placement and to compare the importance of amplicon location versus amplicon length.

Although no short region of the HIV-1 genome is consistently sufficient to distinguish non-clonal full-length viral sequences in all patients, a 1500bp amplicon in the gag-pol region is superior to a 500bp amplicon spanning the envelope V3-V4 region (p<0.001). In sequences from plasma RNA, the sufficiency of a hypothetical amplicon to distinguish non-clonal sequences depends almost entirely on the length of the amplicon. In proviral DNA samples, there is wide variation among patients in terms of which genomic regions work best and in terms of the importance of amplicon length.

No short PCR amplicon is sufficient to demonstrate the clonality of HIV-1 genomes within samples from a single patient. Researchers hoping to demonstrate clonality may screen samples with a short PCR but must ultimately sequence full-length viral genomes to demonstrate the clonality of independent samples.